sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Cancer Therapeutics Market Size & Forecast

Historic: 2021-2023 Base Year: 2024 Forecast: 2025–2031
US$ 230.42 Billion
Market Size 2024 · Base Year
US$ 531.53 Billion
Projected Market Size by 2031
12.68%
CAGR · 2025–2031
SHARE
BMIRE00031299 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
11
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2021–2023), Base Year (2024), and 7-Year Forecast (2025–2031)
10 +
Major Players
Major companies profiled including Astellas Pharma Inc, Eli Lilly and Co, Novartis AG, Merck KGaA, AstraZeneca
539
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Rising Prevalence of Cancer

  • Favorable Reimbursement Scenario for Novel Therapeutics

  • Improvement in Diagnosis Rate of Cancer

Where Growth Opportunities Exist

Key Opportunities

  • Government Intervention across Developing Nations to Improve the Access of Life-saving Drugs

  • Rising Investments in the Development of Advanced Drug Development Platforms

  • Growing Number of Clinical trials for Anticancer Drugs

What Could Slow It Down

Market Restraints

  • High treatment cos

  • Side effect

  • Regulatory hurdles

Market Segmentation

Coverage by Segment

Therapy Type

Chemotherapy
Targeted Therapy
Radiation Therapy

Indications

Blood Cancer
Lung Cancer
Breast Cancer

Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Channel
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Astellas Pharma Inc
Eli Lilly and Co
Novartis AG
Merck KGaA
AstraZeneca
Pfizer Inc
Hoffmann-La Roche Ltd
Johnson & Johnson
AbbVie Inc
Bristol-Myers Squibb Co
What's Inside

Report Scope & Deliverables

Market Size 2024 US$ 230.42 Billion
Market Size 2031 US$ 531.53 Billion
CAGR 2025–2031 12.68%
Segments By Therapy Type (Chemotherapy, Targeted Therapy, Radiation Therapy)  |  By Indications (Blood Cancer, Lung Cancer, Breast Cancer)  |  By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel)
Geographies North America (US, Canada, Mexico)  ·  Europe (Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria)  ·  Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh)  ·  South and Central America (Brazil, Argentina, Chile, Colombia, Peru)  ·  Middle East and Africa (Saudi Arabia, United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIRE00031299
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 539 pages of in-depth Cancer Therapeutics Market, including historical trends, 7-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.